NCT04560140 Promoting Community Reintegration for Young Adults With Stroke
| NCT ID | NCT04560140 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 208 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 208 participants in total. It began in 2021-09-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will investigate the effects of a Narrative and Skills-building Intervention on young stroke survivors' community reintegration and psychosocial outcomes. A randomised controlled trial will be conducted. This is a novel trial to test the short and long-term effects of a theory-based intervention on young stroke survivors' community reintegration.
Eligibility Criteria
Inclusion Criteria: * (1) are 18-64 years of age, * (2) have a clinical diagnosis of first-ever or recurrent ischaemic or haemorrhagic stroke, * (3) are living at home after discharge from hospital, * (4) have a Montreal Cognitive Assessment score \>20, * (5) have a modified Rankin Scale score ≥3, * (6) can communicate in Cantonese, and * (7) are able to attend all intervention sessions. Exclusion Criteria: * 1\) transient ischaemic attack, subdural or epidural haemorrhage, * 2\) experienced cerebrovascular events due to tumours or head trauma, * 3\) mental condition such as depression, schizophrenia, bipolar or personality disorder, * 4\) incomprehensible speech or difficulty in comprehending conversations, or * 5\) have received a self-management programme in the past.
Contact & Investigator
Suzanne Lo
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT04560140 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04560140 currently recruiting?
Yes, NCT04560140 is actively recruiting participants. Contact the research team at suzannelo@cuhk.edu.hk for enrollment information.
Where is the NCT04560140 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT04560140 clinical trial?
NCT04560140 is sponsored by Chinese University of Hong Kong. The principal investigator is Suzanne Lo at Chinese University of Hong Kong. The trial plans to enroll 208 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.